IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq:ELGX) today announced that six-year patient follow-up data from the Company’s Powerlink® System pivotal clinical trial supporting the durability of the Powerlink System as a minimally invasive treatment for abdominal aortic aneurysm (AAA) was published in the peer-reviewed Journal of Vascular Surgery (September 2008). A link to the abstract “The Powerlink System for endovascular abdominal aortic aneurysm repair: Six-year results” is available at www.endologix.com.
